Clinical Trial Update: R2 and Combination Chemotherapy Versus R and Combination Chemotherapy in Newly Diagnosed Highly Aggressive B-NHL [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing R2 and combination chemotherapy versus R and combination chemotherapy in newly diagnosed highly aggressive B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Lymphoma B-cell

Drugs mentioned

• Combination chemotherapy
• R
• R2

Snippet

Sponsor: Shandong Provincial Hospital | Conditions: Lymphoma, B-Cell | Phase 4 | Status: UNKNOWN